These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34043368)

  • 21. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered bile acid glycine : taurine ratio in the progression of chronic liver disease.
    Chen T; Zhou K; Sun T; Sang C; Jia W; Xie G
    J Gastroenterol Hepatol; 2022 Jan; 37(1):208-215. PubMed ID: 34655465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of dysregulated lipid metabolism in diabetic mice via targeted metabolomics of bile acids in enterohepatic circulation.
    Ruan Y; Liu R; Gong L
    Rapid Commun Mass Spectrom; 2022 Mar; 36(6):e9236. PubMed ID: 34897861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
    Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R
    Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum metabolite signatures of type 2 diabetes mellitus complications.
    Wu T; Xie G; Ni Y; Liu T; Yang M; Wei H; Jia W; Ji G
    J Proteome Res; 2015 Jan; 14(1):447-56. PubMed ID: 25245142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.
    Luo L; Aubrecht J; Li D; Warner RL; Johnson KJ; Kenny J; Colangelo JL
    PLoS One; 2018; 13(3):e0193824. PubMed ID: 29513725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case.
    Zhao L; Ma P; Peng Y; Wang M; Peng C; Zhang Y; Li X
    Phytomedicine; 2021 Mar; 83():153477. PubMed ID: 33545549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry.
    Chen Y; Li C; Liu L; Guo F; Li S; Huang L; Sun C; Feng R
    Clin Biochem; 2016 Sep; 49(13-14):962-6. PubMed ID: 27211699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
    Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
    Becker PP; Rau M; Schmitt J; Malsch C; Hammer C; Bantel H; Müllhaupt B; Geier A
    PLoS One; 2015; 10(11):e0142661. PubMed ID: 26565986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal bile acid profile and subtype analysis of intrahepatic cholestasis of pregnancy.
    Shao Y; Chen S; Li H; Tang Q; Xu D
    Orphanet J Rare Dis; 2021 Jun; 16(1):259. PubMed ID: 34098996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Is Associated With Further Left Ventricular Abnormalities in Patients With Type 2 Diabetes Mellitus: A 3-Dimensional Speckle-Tracking Study.
    Wang Q; Ma W; Xia J
    J Ultrasound Med; 2018 Aug; 37(8):1899-1911. PubMed ID: 29363154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
    Bril F; McPhaul MJ; Caulfield MP; Clark VC; Soldevilla-Pico C; Firpi-Morell RJ; Lai J; Shiffman D; Rowland CM; Cusi K
    Diabetes Care; 2020 Feb; 43(2):290-297. PubMed ID: 31604692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity.
    Jimenez-Rivera C; Hadjiyannakis S; Davila J; Hurteau J; Aglipay M; Barrowman N; Adamo KB
    BMC Pediatr; 2017 Apr; 17(1):113. PubMed ID: 28446162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Multimarker Diagnostic Models from Metabolomics Analysis for Gestational Diabetes Mellitus (GDM).
    Hou W; Meng X; Zhao A; Zhao W; Pan J; Tang J; Huang Y; Li H; Jia W; Liu F; Jia W
    Mol Cell Proteomics; 2018 Mar; 17(3):431-441. PubMed ID: 29282297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
    Zhang Y; He H; Zeng YP; Yang LD; Jia D; An ZM; Jia WG
    Lipids Health Dis; 2020 Jun; 19(1):134. PubMed ID: 32527258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis.
    Chen J; Zheng M; Liu J; Luo Y; Yang W; Yang J; Liu J; Zhou J; Xu C; Zhao F; Su M; Zang S; Shi J;
    Obesity (Silver Spring); 2019 Dec; 27(12):2055-2066. PubMed ID: 31657148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
    Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
    Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.